Prof. Roberto Pellicciari

Roberto Pellicciari is Founder and Chief Scientific Advisor of Tes Pharma and Adjunct Professor in the University of Maryland, USA.

He has been Professor of Medicinal Chemistry in the Department of Chemistry and Technology of Drugs, University of Perugia, pre-and postdoctoral fellow in the Istituto Superiore di Sanità, Rome (1964-1968), Visiting Professor in the Universidad de Carabobo, Valencia, Venezuela (1968-1970), Research Associate in the Department of Chemistry, Bloomington Indiana (1970-1973), Visiting Professor in the Department of Chemistry, University of California at San Diego, La Jolla (1981).

Prof. Pellicciari has been Director of the School of Medicinal Chemistry of the Italian Chemical Society (1993-1998), President of the Italian Division of Medicinal Chemistry (2001-2003), President of the European Federation of Medicinal Chemistry (2006-2008).

Prof. Pellicciari has discovered the Obeticholic acid (OCA), a drug for the treatment of the Primary Biliary Cirrhosis, approved on May 2016 by the FDA and currently marketed in the USA.

He is author or co-author of over 350 papers and 50 patents, has given seminars in international congresses and institutions, and he has been the recipient of several awards.